Analysts Weigh-In as Merck (MRK) IMPROVE-IT Set to Run to Completion
Tweet Send to a Friend
This morning Merck (NYSE: MRK) announced that a Data Safety Monitoring Board (DSMB) elected to continue a clinical trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
